You just read:

Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market

News provided by

Frost & Sullivan

25 Jun, 2012, 12:30 BST